Atara Biotherapeutics (ATRA) Non Operating Income (2015 - 2025)
Atara Biotherapeutics (ATRA) reported Non Operating Income of -$843000.0 for Q4 2025, down 847.19% on a YoY basis from $112822.6 in Q4 2024, and down 21175.0% quarter-over-quarter from $4000.0 in Q3 2025.
Atara Biotherapeutics (ATRA) Non Operating Income (2015 - 2025) Analysis & Trends
Atara Biotherapeutics has reported Non Operating Income for 11 years, with the latest figure at -$843000.0 in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income fell 847.19% year-over-year to -$843000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.6 million (down 395.78% YoY), and the FY2025 full-year result was -$3.1 million, down 695.27% from the prior year.
- Non Operating Income for Q4 2025 stood at -$843000.0, down from $4000.0 in the prior quarter.
- The five-year high for Non Operating Income was $50.6 million in Q2 2022, with the low at -$843000.0 in Q4 2025.
- Historically, Non Operating Income has averaged $2.5 million across 5 years, with a median of -$1000.0 in 2024.
- Annual changes were most pronounced in 2022 — Non Operating Income jumped 22388.0% — and 2025, when it plunged 13350.0%.
- Atara Biotherapeutics' Non Operating Income stood at $84000.0 in 2021, then surged by 1053.57% to $969000.0 in 2022, then plunged by 86.69% to $129000.0 in 2023, then sank by 168.99% to -$89000.0 in 2024, then plunged by 847.19% to -$843000.0 in 2025.
- The last three Non Operating Income figures came in at -$843000.0 (Q4 2025), $4000.0 (Q3 2025), and -$807000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 9.35 Mn |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -843,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | -807,000.00 |
| Mar 31, 2025 | -792,000.00 |
| Dec 31, 2024 | -89,000.00 |
| Sep 30, 2024 | 555,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | 129,000.00 |
| Sep 30, 2023 | -27,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | -197,000.00 |
| Dec 31, 2022 | 969,000.00 |
| Sep 30, 2022 | -309,000.00 |
| Jun 30, 2022 | 50.60 Mn |
| Mar 31, 2022 | 115,000.00 |
| Dec 31, 2021 | 84,000.00 |
| Sep 30, 2021 | 148,000.00 |
| Jun 30, 2021 | 225,000.00 |
| Mar 31, 2021 | -90,000.00 |